SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-16-000729
Filing Date
2016-02-12
Accepted
2016-02-12 13:16:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 enzon13ga2.htm SC 13G/A 44751
  Complete submission text file 0000935836-16-000729.txt   46640
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 161417240
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 250 BEND OR 97709
Business Address P.O. BOX 250 BEND OR 97709 541-647-5664
STONEPINE CAPITAL, L.P. (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A